はじめての方へショーケース価格
  1. 米国企業
  2. CATALYST PHARMACEUTICALS, INC.

CATALYST PHARMACEUTICALS, INC.CPRX

時価総額
$19.4億
PER
27.2倍
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Net income--------34,003,5143275398371
Depreciation---26,57434,46843,40645,68937,97854,32792,065000
Amortization of intangible assets-----------133
Stock-based compensation666777,9692224466814
Stock-based compensation666777,9692224466814
Amortization of intangible assets-----------133
Deferred taxes---------33-9-518
Change in accrued interest and accretion of discount on investments--------290,80512,1910-0-
Accretion of discount-------------1
Non cash change in right of use asset--------243,399793,252000
Debt Securities, Available-for-Sale, Realized Loss-----------1-
Acquired research and development inventory expensed from asset acquisition-----------4-
Acquired inventory samples expensed from asset acquisition------------0
Acquired in-process research and development------------82
Change in fair value of equity securities------------3
Accounts receivable, net--------11-4,549,5711443
Inventory-------56,012233-15
Prepaid expenses and other current assets208,004123452,040-456,794125,800476,03734-416
Accounts receivable, net--------11-4,549,5711443
Inventory-------56,012233-15
Prepaid expenses and other current assets208,004123452,040-456,794125,800476,03734-416
Accounts receivable, net--------11-4,549,5711443
Inventory-------56,012233-15
Prepaid expenses and other current assets208,004123452,040-456,794125,800476,03734-416
Accounts receivable, net--------11-4,549,5711443
Inventory-------56,012233-15
Prepaid expenses and other current assets208,004123452,040-456,794125,800476,03734-416
Accounts payable263,9341850,789963,421-20,083-860,9511391,7922138,573-1111
Accrued expenses and other liabilities516,033239,528131-480,2481513-1,209,2806166
Operating lease liability--------276,807919,2801-0-0
Accounts payable263,9341850,789963,421-20,083-860,9511391,7922138,573-1111
Accrued expenses and other liabilities516,033239,528131-480,2481513-1,209,2806166
Operating lease liability--------276,807919,2801-0-0
Accounts payable263,9341850,789963,421-20,083-860,9511391,7922138,573-1111
Accrued expenses and other liabilities516,033239,528131-480,2481513-1,209,2806166
Operating lease liability--------276,807919,2801-0-0
Accounts payable263,9341850,789963,421-20,083-860,9511391,7922138,573-1111
Accrued expenses and other liabilities516,033239,528131-480,2481513-1,209,2806166
Operating lease liability--------276,807919,2801-0-0
Net cash provided by (used in) operating activities-4,985,049-5,140,366-9,875,674-----25,704,406354560116144
Net cash provided by (used in) operating activities-4,985,049-5,140,366-9,875,674-----25,704,406354560116144
Purchases of property and equipment102,826155,208164,64057,32323,46596,061-92,01819,36911,398100
Purchases of investments-------37351010--
Proceeds from sale of available-for-sale securities-----------19-
Payment in connection with license agreement-----------10-
Purchases of property and equipment102,826155,208164,64057,32323,46596,061-92,01819,36911,398100
Net cash provided by (used in) investing activities-3,620-14,059,651-7,496,801-----15,526,01137-5,011,398-119-294
Purchases of investments-------37351010--
Proceeds from sale of available-for-sale securities-----------19-
Payments in connection with asset acquisitions------------198
Acquisition of in-process research and development------------82
Purchase of equity securities------------13
Net cash provided by (used in) investing activities-3,620-14,059,651-7,496,801-----15,526,01137-5,011,398-119-294
Purchases of property and equipment102,826155,208164,64057,32323,46596,061-92,01819,36911,398100
Purchases of investments-------37351010--
Proceeds from sale of available-for-sale securities-----------19-
Payment in connection with license agreement-----------10-
Purchases of property and equipment102,826155,208164,64057,32323,46596,061-92,01819,36911,398100
Net cash provided by (used in) investing activities-3,620-14,059,651-7,496,801-----15,526,01137-5,011,398-119-294
Purchases of investments-------37351010--
Proceeds from sale of available-for-sale securities-----------19-
Payments in connection with asset acquisitions------------198
Acquisition of in-process research and development------------82
Purchase of equity securities------------13
Net cash provided by (used in) investing activities-3,620-14,059,651-7,496,801-----15,526,01137-5,011,398-119-294
Payment of employee withholding tax related to stock-based compensation3,4103,4103,410--11,265-4,448-56,197001
Proceeds from Stock Options Exercised--23,500522,000390,35180,251368,185297,5631758,1304103
Repurchase of common stock----------127-
Payment of liabilities arising from asset acquisition-----------113
Net cash provided by (used in) financing activities375270----293,1151701,933-82-11
Payment of employee withholding tax related to stock-based compensation3,4103,4103,410--11,265-4,448-56,197001
Proceeds from Stock Options Exercised--23,500522,000390,35180,251368,185297,5631758,1304103
Repurchase of common stock----------127-
Payment of liabilities arising from asset acquisition-----------113
Net cash provided by (used in) financing activities375270----293,1151701,933-82-11
Payment of employee withholding tax related to stock-based compensation3,4103,4103,410--11,265-4,448-56,197001
Proceeds from Stock Options Exercised--23,500522,000390,35180,251368,185297,5631758,1304103
Repurchase of common stock----------127-
Payment of liabilities arising from asset acquisition-----------113
Net cash provided by (used in) financing activities375270----293,1151701,933-82-11
Payment of employee withholding tax related to stock-based compensation3,4103,4103,410--11,265-4,448-56,197001
Proceeds from Stock Options Exercised--23,500522,000390,35180,251368,185297,5631758,1304103
Repurchase of common stock----------127-
Payment of liabilities arising from asset acquisition-----------113
Net cash provided by (used in) financing activities375270----293,1151701,933-82-11
Net increase (decrease) in cash and cash equivalents--------734141127-161
Income Taxes Paid---------33850
Income Taxes Paid---------33850
Cash paid for interest------------1
Operating lease liabilities arising from obtaining right-of-use assets----------3--
Liabilities arising from asset acquisition-----------282
Operating lease liabilities arising from obtaining right-of-use assets----------3--
Liabilities arising from asset acquisition-----------282
Net increase (decrease) in cash and cash equivalents--------734141127-161
Income Taxes Paid---------33850
Income Taxes Paid---------33850
Cash paid for interest------------1
Operating lease liabilities arising from obtaining right-of-use assets----------3--
Liabilities arising from asset acquisition-----------282
Operating lease liabilities arising from obtaining right-of-use assets----------3--
Liabilities arising from asset acquisition-----------282